Published in Dtsch Med Wochenschr on May 04, 1973
Clinical trial of glibornuride in diabetes. Br Med J (1975) 0.97
Effect of glibornuride on diabetic control and glucose tolerance. J R Soc Med (1978) 0.75
Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother (1996) 6.01
Novel mechanism of macrolide resistance in Streptococcus pneumoniae. Diagn Microbiol Infect Dis (1996) 3.29
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol (2004) 2.65
A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob Agents Chemother (1997) 2.63
Cognitive processes mediating behavioral change. J Pers Soc Psychol (1977) 2.46
Antibody to hepatitis C virus in German blood donors. Lancet (1989) 2.21
Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori. Helicobacter (1996) 2.10
Development of a standardized susceptibility test for campylobacter with quality-control ranges for ciprofloxacin, doxycycline, erythromycin, gentamicin, and meropenem. Microb Drug Resist (2004) 1.97
Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group. J Clin Oncol (2003) 1.86
The UL97 gene product of human cytomegalovirus is an early-late protein with a nuclear localization but is not a nucleoside kinase. J Virol (1996) 1.63
Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes. Antimicrob Agents Chemother (1994) 1.62
Marked increase of the growth factors pleiotrophin and fibroblast growth factor-2 in serum of testicular cancer patients. Ann Oncol (2003) 1.53
Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors. Ann Oncol (2012) 1.49
Comparison of glycemic response and insulin requirements after mixed meals of equal carbohydrate content in healthy, type-1, and type-2 diabetic man. Klin Wochenschr (1989) 1.46
Identification of a novel viral protein in infectious bursal disease virus-infected cells. J Gen Virol (1995) 1.45
Interactive Volume Exploration of Petascale Microscopy Data Streams Using a Visualization-Driven Virtual Memory Approach. IEEE Trans Vis Comput Graph (2012) 1.45
Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.43
Hepatitis C viremia in German blood donors: serum alanine aminotransferase is not a valid marker for screening. Transfusion (1994) 1.40
Abnormal pentagastrin response in a patient with pseudohypoparathyroidism. Exp Clin Endocrinol Diabetes (2002) 1.40
Biocompatibility of alginates for grafting: impact of alginate molecular weight. Artif Cells Blood Substit Immobil Biotechnol (2003) 1.40
[Predictive genetic investigations. Individualization of diagnosis and treatment in families with multiple endocrine neoplasia type II]. Dtsch Med Wochenschr (2000) 1.38
Molecular typing of Helicobacter pylori isolates from a multicenter U.S. clinical trial by ureC restriction fragment length polymorphism. J Clin Microbiol (1997) 1.37
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor. Bone Marrow Transplant (2003) 1.31
Induction of ribosome methylation in MLS-resistant Streptococcus pneumoniae by macrolides and ketolides. Microb Drug Resist (1999) 1.30
Axonal transport of adeno-associated viral vectors is serotype-dependent. Gene Ther (2012) 1.29
Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome. Cancer (2001) 1.29
Transport and storage of Helicobacter pylori from gastric mucosal biopsies and clinical isolates. Eur J Clin Microbiol Infect Dis (1995) 1.25
Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors. J Natl Cancer Inst (2000) 1.21
Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short- and long-term graft function. Kidney Int (2006) 1.21
Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy. Free Radic Res (1999) 1.19
Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study. J Hypertens (1996) 1.18
Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer. J Clin Oncol (1999) 1.17
First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis. J Clin Oncol (1999) 1.16
Ciclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized and prospective study. Eur J Clin Invest (1986) 1.16
In vitro and in vivo evaluations of A-80556, a new fluoroquinolone. Antimicrob Agents Chemother (1994) 1.15
The effect of human proinsulin C-peptide on erythrocyte deformability in patients with Type I diabetes mellitus. Diabetologia (1999) 1.14
Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials. Exp Clin Endocrinol Diabetes (1999) 1.13
Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group. J Clin Oncol (2002) 1.11
Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer. Ann Oncol (1996) 1.10
Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors. Ann Oncol (2002) 1.09
The influence of PEEP ventilation on organ blood flow and peripheral oxygen delivery. Intensive Care Med (1982) 1.09
Multilayer capsules: a promising microencapsulation system for transplantation of pancreatic islets. Biomaterials (2001) 1.09
Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus. J Clin Invest (1998) 1.08
Prolonged application of pressure in transluminal coronary angioplasty. Cathet Cardiovasc Diagn (1984) 1.08
Intranasal GnRH therapy of maldescended testes. Horm Metab Res (1975) 1.07
A second form of infectious bursal disease virus-associated tubule contains VP4. J Virol (1997) 1.07
Detection of four different 11q23 chromosomal abnormalities by multiplex-PCR and fluorescence-based automatic DNA-fragment analysis. Leukemia (1995) 1.06
Bone mineral density and bone metabolism in diabetes mellitus. Horm Metab Res (1997) 1.06
Serum leptin is associated with serum uric acid concentrations in humans. Metabolism (1999) 1.05
In vitro evaluation of ABT-719, a novel DNA gyrase inhibitor. Antimicrob Agents Chemother (1995) 1.05
Bridging anticoagulation for patients on long-term vitamin-K-antagonists. A prospective 1 year registry of 311 episodes. J Thromb Haemost (2005) 1.05
Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis. J Clin Oncol (2001) 1.04
Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia. Ann Hematol (2003) 1.03
Comparative in vitro activity of ABT-773, a novel antibacterial ketolide. Antimicrob Agents Chemother (2001) 1.02
Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer. J Clin Oncol (2001) 1.02
[Polyglandular autoimmune syndrome type II: epidemiology and forms of manifestation]. Dtsch Med Wochenschr (1999) 1.01
American Academy of Pediatrics Report of the Subcommittee on Assessment and Methodologic Issues in the Management of Pain in Childhood Cancer. Pediatrics (1990) 0.98
Fracture of ceramic heads in total hip replacement. Arch Orthop Trauma Surg (2006) 0.98
Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study. J Thromb Haemost (2007) 0.97
Long-acting and selective suppression of growth hormone secretion by somatostatin analogue SMS 201-995 in acromegaly. Lancet (1984) 0.96
Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I. Clin Sci (Lond) (2000) 0.96
Evidence for a participation of the kallikrein-kinin system in the regulation of muscle metabolism during muscular work. FEBS Lett (1977) 0.96
Reversed portal vein pulsatility on Doppler ultrasound secondary to an iatrogenic mediastinal haematoma. Br J Radiol (2001) 0.96
High-dose chemotherapy in germ cell tumours: a large single centre experience. Eur J Cancer (1998) 0.95
Blepharmone: a conjugation-inducing glycoprotein in the ciliate blepharisma. Science (1974) 0.95
Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin-dependent diabetes mellitus. Eur J Clin Invest (1987) 0.95
Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: candidates for a signal transmitter defect causing insulin resistance of the skeletal muscle. Diabetologia (1993) 0.95
Epidemiology and immunogenetic background of islet cell antibody--positive nondiabetic schoolchildren. Ulm-Frankfurt population study. Diabetes (1991) 0.95
Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy. Diabet Med (1999) 0.94
The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors. Cancer (2000) 0.94
Eligibility for home treatment of deep vein thrombosis: prospective study. BMJ (2001) 0.94
Insulin action on glucose uptake into skeletal muscle: inhibition of endogenous biosynthesis of prostaglandins. FEBS Lett (1978) 0.93
HLA antigens and immunoresponsiveness to insulin in insulin-dependent diabetes mellitus. Tissue Antigens (1976) 0.92
Comparative studies on intermediary metabolism and hormonal counterregulation following human insulin (recombinant DNA) and purified pork insulin in man. Diabetes Care (1987) 0.92
Initiating oral glucose-lowering therapy with metformin in type 2 diabetic patients: an evidence-based strategy to reduce the burden of late-developing diabetes complications. Diabetes Metab (2004) 0.92
Peripheral osteopenia in adult patients with insulin-dependent diabetes mellitus. Diabet Med (1995) 0.92
Peripheral vascular disease in diabetes mellitus and its relation to cardiovascular risk factors: screening with the doppler ultrasonic technique. Diabetes Care (1980) 0.91
[Questioning of diabetic patients on their knowledge of nutrition and dietetics as well as on their smoking habits]. Infusionsther Klin Ernahr (1976) 0.91
Therapy of isolated calf muscle vein thrombosis with low-molecular-weight heparin. Blood Coagul Fibrinolysis (2001) 0.91
[Assessment of oral glucose tolerance]. Dtsch Med Wochenschr (1972) 0.91
Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors. J Clin Oncol (1998) 0.90
[On the behavior of the blood insulin level after glucose tolerance testing in maternity cases, in relation to the weight of the newborn]. Klin Wochenschr (1966) 0.90
Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes. Exp Clin Endocrinol Diabetes (1996) 0.90
Kill kinetics of antimicrobial agents against Helicobacter pylori. J Antimicrob Chemother (1996) 0.90
HLA-associated insulin autoantibody formation in newly diagnosed type I diabetic patients. Diabetes (1991) 0.90
The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group. Semin Oncol (1998) 0.90
Hypoglycemia in hypertensive diabetic patients treated with sulfonylureas, biguanides, and captopril. N Engl J Med (1988) 0.90
Comparison of metabolic clearance rates of MCT/LCT and LCT emulsions in diabetics. JPEN J Parenter Enteral Nutr (1988) 0.90
Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects. Diabetologia (1971) 0.89
Alpha-lipoic acid reduces expression of vascular cell adhesion molecule-1 and endothelial adhesion of human monocytes after stimulation with advanced glycation end products. Clin Sci (Lond) (1999) 0.89
Pseudorabies virus expressing bovine herpesvirus 1 glycoprotein B exhibits altered neurotropism and increased neurovirulence. J Virol (2000) 0.89
Binding of monocytes from normolipidemic hyperglycemic patients with type 1 diabetes to endothelial cells is increased in vitro. Exp Clin Endocrinol Diabetes (1999) 0.89
Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study Group. J Clin Oncol (2004) 0.88
Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors. J Natl Cancer Inst (2001) 0.88
New aspects of insulin resistance in hypertension. Eur Heart J (1994) 0.88
Changes of hepatic morphology during parenteral nutrition with lipid emulsions containing LCT or MCT/LCT quantified by ultrasound. JPEN J Parenter Enteral Nutr (1992) 0.88